(Q37785176)

23 August 2017

title

Management of voltage-gated potassium channel antibody disorders (English)

1 reference

23 August 2017

Management of Voltage-Gated Potassium Channel Antibody Disorders (English)

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

6 July 2024

1 reference

0 references

Michael P. Merchut

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816272

6 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816272

6 July 2024

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0733861910000629?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

https://api.elsevier.com/content/article/PII:S0733861910000629?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

6 July 2024

1 reference

23 August 2017

volume

28

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

941-959

1 reference

Autoimmune Disorders of Neuronal Potassium Channels

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations

6 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Persistent facial myokymia associated with K(+) channel antibodies

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Cramp,fasciculation syndrome: A treatable hyperexcitable peripheral nerve disorder

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Autoimmune aetiology for acquired neuromyotonia

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Improvement of Isaacs' syndrome after treatment with azathioprine

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Volitional and stimulation induced neuromyotonic discharges: unusual electrophysiological pattern in acquired neuromyotonia

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis.

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Acquired neuromyotonia in childhood: case report and review

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Isaacs' syndrome: clinical and electrophysiological response to gabapentin

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Potassium channel antibodies in two patients with reversible limbic encephalitis

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

6 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Clinical, Magnetic Resonance Imaging, and Electroencephalographic Findings in Paraneoplastic Limbic Encephalitis

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Voltage‐gated potassium channel antibodies in limbic encephalitis

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Voltage-gated potassium channel antibody-associated encephalitis with basal ganglia lesions

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report.

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

A case of voltage-gated potassium channel antibody-related limbic encephalitis

6 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome.

6 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Hypothermia in VGKC antibody-associated limbic encephalitis.

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Voltage-gated potassium channel antibody-mediated syndromes: a spectrum of clinical manifestations

6 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction

6 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis

6 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma

6 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

6 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Generalized myokymia and gold therapy

6 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Morvan's fibrillary chorea: remission after plasmapheresis

6 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Morvan's fibrillary chorea. Electrodiagnostic and in vitro microelectrode findings.

6 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea

6 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Morvan's syndrome associated with voltage-gated K+ channel antibodies

6 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Sub-acute presentation of Morvan's syndrome after thymectomy

6 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Neurophysiologic studies in Morvan syndrome

6 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome

6 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

An interesting case report of Morvan's syndrome from the Indian subcontinent

6 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies.

6 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

fasciculations, autonomic symptoms and limbic encephalitis: a thymoma-associated Morvan's-like syndrome.

6 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NCL.2010.03.024

6 July 2024

Identifiers

1 reference

23 August 2017

1 reference